Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Su TH"" wg kryterium: Autor


Tytuł :
Paradigm Shift in the Treatment Options of Hepatocellular Carcinoma.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Hsu SJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yunlin, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2021 Sep 13. Date of Electronic Publication: 2021 Sep 13.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load.
Autorzy :
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Yang WT; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Hsu CY; Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Hong CM; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tsai CH; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen HH; Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Apr; Vol. 53 (8), pp. 908-918. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B, Chronic*/complications
DNA, Viral ; Disease Progression ; Hepatitis B Core Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Symptom Flare Up ; Viral Load
Czasopismo naukowe
Tytuł :
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Hung CC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan.
Hsieh SM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Sun HY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Apr; Vol. 40 (4), pp. 758-768. Date of Electronic Publication: 2019 Nov 11.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis C, Chronic*/drug therapy
Aminoisobutyric Acids ; Antiviral Agents/adverse effects ; Benzimidazoles ; Cyclopropanes ; Far East ; Genotype ; Hepacivirus/genetics ; Humans ; Lactams, Macrocyclic ; Leucine/analogs & derivatives ; Proline/analogs & derivatives ; Quinoxalines ; Retrospective Studies ; Sulfonamides ; Taiwan
Czasopismo naukowe
Tytuł :
Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. Authors' reply.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jan; Vol. 51 (2), pp. 310-311.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Hepatitis B*
Hepatitis B, Chronic*
Lymphoma, Non-Hodgkin*
Multiple Myeloma*
B-Lymphocytes ; Hepatitis B virus ; Humans
Raport
Tytuł :
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chou SW; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Wu SJ; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Mar; Vol. 49 (5), pp. 589-598. Date of Electronic Publication: 2019 Jan 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B virus*
Hepatitis B/*epidemiology
Hepatitis B, Chronic/*epidemiology
Lymphoma, B-Cell/*epidemiology
Multiple Myeloma/*epidemiology
Adult ; Aged ; Cohort Studies ; Comorbidity ; Female ; Follow-Up Studies ; Hepatitis B/diagnosis ; Hepatitis B, Chronic/diagnosis ; Humans ; Longitudinal Studies ; Lymphoma, B-Cell/diagnosis ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Risk Factors ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chou SW; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Wu SJ; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Feb; Vol. 49 (3), pp. 331-339. Date of Electronic Publication: 2018 Dec 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*administration & dosage
Hepatitis C, Chronic/*drug therapy
Lymphoma/*prevention & control
Adult ; Antiviral Agents/therapeutic use ; Cohort Studies ; Drug Therapy, Combination ; Female ; Humans ; Incidence ; Interferon-alpha/therapeutic use ; Lymphoma/epidemiology ; Male ; Middle Aged ; Polyethylene Glycols/chemistry ; Ribavirin/therapeutic use ; Taiwan
Czasopismo naukowe
Tytuł :
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection.
Autorzy :
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, New Taipei City, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Su TH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Yang WT; Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Yang HC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Microbiology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Kuo SF; Royal Hobart Hospital, Hobart, Australia.
Liu CH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Genomics Research Center Academia Sinica, Taipei, Taiwan.
Kao JH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2018 Jun; Vol. 47 (11), pp. 1480-1489. Date of Electronic Publication: 2018 Mar 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B virus*
Hepatitis B, Chronic/*blood
Hepatitis B, Chronic/*mortality
Liver Cirrhosis/*blood
Liver Cirrhosis/*mortality
Adult ; Biomarkers/blood ; Disease Progression ; Female ; Follow-Up Studies ; Hepatitis B Surface Antigens/blood ; Hepatitis B, Chronic/diagnosis ; Humans ; Male ; Middle Aged ; Mortality/trends ; Predictive Value of Tests ; Risk Factors
Czasopismo naukowe
Tytuł :
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Douliou, Taiwan.
Sun HY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Sheng WH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Hsieh SM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Lo YC; Centers for Disease Control, Taipei, Taiwan.
Liu WC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Hong CM; Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research, Center, Academia Sinica, Taipei, Taiwan.
Hung CC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2018 Jun; Vol. 47 (12), pp. 1690-1698. Date of Electronic Publication: 2018 Apr 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*administration & dosage
Carbamates/*administration & dosage
Hepatitis C/*drug therapy
Heterocyclic Compounds, 4 or More Rings/*administration & dosage
Sofosbuvir/*administration & dosage
Adult ; Aged ; Antiviral Agents/therapeutic use ; Coinfection ; Drug Combinations ; Female ; HIV Infections/drug therapy ; Hepacivirus/isolation & purification ; Humans ; Male ; Middle Aged ; Ribavirin/therapeutic use ; Sustained Virologic Response ; Taiwan ; Tenofovir/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma.
Autorzy :
Kuo YC; Division of Gastroenterology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.; Health Evaluation Center, Mackay Memorial Hospital, Taipei, Taiwan.; Mackay Medicine, Nursing and Management College, Taipei, Taiwan.
Shih SC; Division of Gastroenterology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.; Health Evaluation Center, Mackay Memorial Hospital, Taipei, Taiwan.; Mackay Medicine, Nursing and Management College, Taipei, Taiwan.; Mackay Medical College, Taipei, Taiwan.
Yu LY; Division of Gastroenterology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.; Health Evaluation Center, Mackay Memorial Hospital, Taipei, Taiwan.; Mackay Medicine, Nursing and Management College, Taipei, Taiwan.
Wu MS; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Su TH; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Liu CJ; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Hu KC; Division of Gastroenterology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.; Health Evaluation Center, Mackay Memorial Hospital, Taipei, Taiwan.; Mackay Medicine, Nursing and Management College, Taipei, Taiwan.; Mackay Medical College, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Helicobacter [Helicobacter] 2018 Apr; Vol. 23 (2), pp. e12473. Date of Electronic Publication: 2018 Feb 26.
Typ publikacji :
Letter
MeSH Terms :
Adenoma/*microbiology
Colorectal Neoplasms/*microbiology
Helicobacter Infections/*microbiology
Helicobacter pylori/*physiology
Hyperglycemia/*microbiology
Adenoma/complications ; Adult ; Age Factors ; Blood Glucose/metabolism ; Colorectal Neoplasms/complications ; Female ; Helicobacter Infections/complications ; Helicobacter Infections/metabolism ; Helicobacter pylori/genetics ; Humans ; Hyperglycemia/complications ; Hyperglycemia/metabolism ; Male ; Middle Aged ; Sex Factors
Opinia redakcyjna
Tytuł :
Temporal Trends in Treatment and Outcomes of Acute Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Observational Study.
Autorzy :
Su TH; Department of Emergency Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan.
Chang SH; Department of Cardiology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Chen PC; Department of Public Health, China Medical University, Taichung, Taiwan.; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
Chan YL; Department of Emergency Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan .
Pokaż więcej
Źródło :
Journal of the American Heart Association [J Am Heart Assoc] 2017 Mar 15; Vol. 6 (3). Date of Electronic Publication: 2017 Mar 15.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Disease Management*
Forecasting*
Population Surveillance*
Myocardial Infarction/*therapy
Outcome Assessment, Health Care/*trends
Pulmonary Disease, Chronic Obstructive/*complications
Aged ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Morbidity/trends ; Myocardial Infarction/complications ; Myocardial Infarction/epidemiology ; Pulmonary Disease, Chronic Obstructive/epidemiology ; ROC Curve ; Retrospective Studies ; Survival Rate/trends ; Taiwan/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies